Empowered Funds, LLC Medtronic PLC Transaction History

Empowered Funds, LLC

$9.4 Billion
Q3 2025

A detailed history of Empowered Funds, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Empowered Funds, LLC holds 91,039 shares of MDT stock, worth $8.77 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

91,039

Previous 141,713 35.76%

Holding current value

$8.77 Million

Previous $12.4 Million 29.81%

% of portfolio

0.09%

Previous 0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$87.67 - $95.74 $4.44 Million - $4.85 Million	-50,674 Reduced 35.76%	91,039 $8.67 Million
Q2 2025 Aug 11, 2025	BUY	$80.68 - $88.86 $2.89 Million - $3.18 Million	35,790 Added 33.79%	141,713 $12.4 Million
Q1 2025 May 16, 2025	BUY	$79.84 - $94.5 $8,063 - $9,544	101 Added 0.1%	105,923 $9.52 Million
Q4 2024 Jan 28, 2025	BUY	$79.61 - $92.24 $221,156 - $256,242	2,778 Added 2.7%	105,822 $8.45 Million
Q3 2024 Nov 06, 2024	SELL	$76.84 - $91.03 $499,306 - $591,512	-6,498 Reduced 5.93%	103,044 $9.28 Million

Q2 2024 Jul 30, 2024	BUY	$78.71 - $87.02 $2.73 Million - $3.01 Million	34,639 Added 46.25%	109,542 $8.62 Million
Q1 2024 May 06, 2024	BUY	$82.84 - $88.09 $4.24 Million - $4.51 Million	51,214 Added 216.19%	74,903 $6.53 Million
Q3 2023 Nov 01, 2023	BUY	$78.22 - $90.4 $385,311 - $445,310	4,926 Added 26.25%	23,689 $1.86 Million
Q2 2023 Jul 27, 2023	BUY	$79.47 - $91.38 $761,004 - $875,054	9,576 Added 104.23%	18,763 $1.65 Million
Q1 2023 Apr 05, 2023	BUY	$76.72 - $87.58 $282,789 - $322,819	3,686 Added 67.01%	9,187 $740,000
Q4 2022 Jan 26, 2023	BUY	$76.18 - $87.74 $419,066 - $482,657	5,501 New	5,501 $427,000

Others Institutions Holding MDT

# of Institutions

2,501

Shares Held

1.07B

Call Options Held

9.37M

Put Options Held

6.41M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $128B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Account

Empowered Funds, LLC Medtronic PLC Transaction History